These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15770932)

  • 21. Dialysis: The importance of peritoneal catheter exit-site care.
    Piraino B
    Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exit site-tunnel infection rate in Tenckhoff catheter with a 2.3 diameter exit site-tunnel section.
    Zappacosta AR
    Perit Dial Int; 1995; 15(1):87. PubMed ID: 7734575
    [No Abstract]   [Full Text] [Related]  

  • 24. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment.
    Riu S; Ruiz CG; Martinez-Vea A; Peralta C; Oliver JA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1870-1. PubMed ID: 9681752
    [No Abstract]   [Full Text] [Related]  

  • 26. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An analysis of methods to prevent peritoneal dialysis catheter infections.
    Piraino B; Bernardini J; Bender FH
    Perit Dial Int; 2008; 28(5):437-43. PubMed ID: 18708532
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters.
    Johnson DW; MacGinley R; Kay TD; Hawley CM; Campbell SB; Isbel NM; Hollett P
    Nephrol Dial Transplant; 2002 Oct; 17(10):1802-7. PubMed ID: 12270988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic prophylaxis: is it needed for dialysis access procedures?
    Salman L; Asif A
    Semin Dial; 2009; 22(3):297-9. PubMed ID: 19573010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
    Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical antibiotics prophylaxis for infections of indwelling pleural/peritoneal catheters (TAP-IPC): A pilot study.
    Lau EPM; Faber S; Charlesworth C; Morey S; Vekaria S; Filion P; Chakera A; Lee YCG
    Respirology; 2024 Feb; 29(2):176-182. PubMed ID: 37696757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of catheter related infections in patients on CAPD.
    Thodis E; Passadakis P; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2001 Oct; 24(10):671-82. PubMed ID: 11817317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment.
    Thodis E; Passadakis P; Ossareh S; Panagoutsos S; Vargemezis V; Oreopoulos DG
    Int J Artif Organs; 2003 Aug; 26(8):698-714. PubMed ID: 14521167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exit-site care in peritoneal dialysis patients.
    Twardowski ZJ
    Perit Dial Int; 1994; 14 Suppl 3():S39-42. PubMed ID: 7948274
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.
    Lo MW; Mak SK; Wong YY; Lo KC; Chan SF; Tong GM; Lo KY; Wong PN; Tse CW; Kam KM; Wong AK
    Perit Dial Int; 2013; 33(3):267-72. PubMed ID: 23032088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.